Possibility of Using the Embryo Fetoplacental Complex Products to Correct Apoptotic Processes under Autoimmune Diseases

Authors

  • A. N. Goltsev
  • V. I. Grischenko
  • I. V. Rassokha
  • M. V. Ostankov

Keywords:

apoptosis, rheumatoid arthritis, products of embryo fetoplacental complex

Abstract

The authors have studied the activity of immune competent cells in an experimental model of rheumatoid arthritis in mice. There was demonstrated the possibility to apply the products of embryo fetoplacental complex (PEFPC) to modulate the apoptotic processes under autoimmune diseases (AIDs).

 

Author Biographies

A. N. Goltsev

Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv

 

V. I. Grischenko

Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv

I. V. Rassokha

Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv

M. V. Ostankov

Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv

Downloads

Published

2003-12-25

How to Cite

Goltsev, A. N., Grischenko, V. I., Rassokha, I. V., & Ostankov, M. V. (2003). Possibility of Using the Embryo Fetoplacental Complex Products to Correct Apoptotic Processes under Autoimmune Diseases. Problems of Cryobiology and Cryomedicine, (4), 41–48. Retrieved from http://cryo.org.ua/journal/index.php/probl-cryobiol-cryomed/article/view/1077

Issue

Section

Theoretical and Experimental Cryobiology